Edelman Joseph's Form 4 filing
Astria Therapeutics, Inc. (ATXS) · filed Oct 18, 2023
- Accession no.
- 0001062993-23-019533
- Filed
- Oct 18, 2023, 4:11 PM ET
- Trade date
- Oct 16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 4 derivative transactions. Open-market purchases total $7.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edelman JosephCIK 0001164426 | Director |
| Perceptive Advisors LLCCIK 0001224962 | Director |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | Director |
| Perceptive Xontogeny Venture Fund, LPCIK 0001757940 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | Common Stock | PPurchaseAcquired | +614,062 | $6.51 | +$3,999,999.87 | 1,652,371 | Indirect | |
| Oct 16, 2023 | Common Stock | PPurchaseAcquired | +460,546 | $6.51 | +$2,999,996.64 | 1,611,699 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | Common Stock | PPurchaseAcquired | +460,546 | $6.51 | +$3,999,999.87 | 460,546 | Indirect | |
| Oct 16, 2023 | Common Stock | PPurchaseAcquired | +690,819 | $6.51 | +$5,999,078.71 | 1,151,366.25 | Indirect | |
| Oct 16, 2023 | Common Stock | PPurchaseAcquired | +921,093 | $6.51 | +$5,999,078.71 | 921,093 | Indirect | |
| Oct 16, 2023 | Common Stock | PPurchaseAcquired | +345,409 | $6.51 | +$2,999,996.64 | 345,409 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.